    
|
 
|
|
|
2008 AACR Annual Meeting, April 12-16, 2008, San Diego, CA
|
Abstracts: Search abstract here
- 2445: OSU-HDAC42, a novel histone deacetylase inhibitor with potent antitumor effects on human and canine osteosarcoma cells
- 2565: OSU-03012 stimulates PERK-dependent increases in HSP70 expression, attenuating its lethal actions in transformed cells
- 2314: A novel celecoxib derivate, OSU03012, induces caspase-dependent cytotoxicity and cell cycle arrest in neuroblastoma
- 1331: Sorafenib, a multi-target inhibitor, and OSU-03012, a phosphoinositide- dependent kinase-1 inhibitor, are synergistic in cytotoxicity against nasopharyngeal carcinoma cells
|
|
|
|
|